| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 06/06/2007 | CN1977045A SARS nucleic acids, proteins, vaccines, and uses thereof |
| 06/06/2007 | CN1976712A Medical solution, method for producing and use thereof |
| 06/06/2007 | CN1974570A Fused pyrrolocarbazoles against inflammation |
| 06/06/2007 | CN1319532C Use of N-(indolecarbonyl-)piperazine derivatives |
| 06/05/2007 | US7226944 As antitumor agent |
| 06/05/2007 | US7226941 Compound for treating angiogenesis |
| 06/05/2007 | US7226937 Methods for modulating phototoxicity |
| 06/05/2007 | US7226902 Complex of a TGF-beta binding protein and a BMP antagonist where the TGF-beta binding protein comprises a sclerostin polypeptide capable of specifically binding a first TGF-beta superfamily member polypeptide from a BMP-5 polypeptide and a BMP-6 polypeptide |
| 06/05/2007 | US7226614 segmented; sustained release; for treatment of allergies |
| 05/31/2007 | WO2005048918A3 Anthrax vaccine |
| 05/31/2007 | WO2005032483A3 Polysaccharides for pulmonary delivery of active agents |
| 05/31/2007 | WO2004100882A3 Inhibition of drug binding to serum albumin |
| 05/31/2007 | WO2002094185A3 Conjugates and compositions for cellular delivery |
| 05/31/2007 | US20070123588 Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements |
| 05/31/2007 | US20070123561 Preparation of 1,7-disubstituted azabensimidazoles as kinase inhibitors |
| 05/31/2007 | US20070123523 Inhibitors of cathepsin s |
| 05/31/2007 | US20070123491 Podophyllotoxin derivatives as igf-1r inhibitors |
| 05/31/2007 | US20070123466 Method of treating recurrent miscarriages |
| 05/31/2007 | US20070123464 Methods and reagents for treating inflammation and fibrosis |
| 05/31/2007 | US20070123455 Immunomodulatory agents for treatment of inflammatory diseases |
| 05/31/2007 | US20070122891 Strain of sorangium cellulosum for generation of epothilone derivatives; antitumor agents |
| 05/31/2007 | US20070122807 Posh polypeptides, complexes and related methods |
| 05/31/2007 | US20070122501 Formulations containing astragalus extracts and uses thereof |
| 05/31/2007 | US20070122487 (Poly(acryloyl-hydroxyethyl starch)-plga composition microspheres |
| 05/31/2007 | US20070122484 Parenterally administrable microparticles |
| 05/31/2007 | US20070122424 Peptide-based vaccine for influenza |
| 05/31/2007 | US20070122419 Methods and compositions for treating atherosclerosis |
| 05/31/2007 | US20070122384 Method for treating inflammatory bowel disease |
| 05/30/2007 | EP1790642A1 Biologically active methylene blue derivatives |
| 05/30/2007 | EP1790348A2 Use of uridine for the treatment of inflammations and/or hemostasis |
| 05/30/2007 | EP1789083A1 Prevention of allergy in children |
| 05/30/2007 | EP1789060A1 Compositions comprising compounds capable of forming a reversible bond or association with gaseous nitric oxide |
| 05/30/2007 | CN1972713A Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor |
| 05/30/2007 | CN1972683A Composition comprising lactic acid and lactoferrin |
| 05/30/2007 | CN1969859A Norepinephrine reuptake inhibitors and methods of using the same |
| 05/29/2007 | US7223789 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/29/2007 | US7223408 Human papillomavirus E6 and E7 polypeptides, mutant polypeptide retains 30% of the immunogenicity of an isolated polypeptide comprising human wild-type papillomavirus E6 and E7 |
| 05/29/2007 | US7223381 Pressurised metered dose inhalers (MDI) |
| 05/24/2007 | WO2005046610A3 Genes differentially expressed by acutely isolated resident progenitor cells of the human white matter |
| 05/24/2007 | WO2005011617A3 Transmucosal dosage forms for brain-targeted steroid chemical delivery systems |
| 05/24/2007 | WO2004087071A3 Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection |
| 05/24/2007 | WO2004060266A3 Eye-drop vaccine containing copolymer poly-ye for therapeutic immunization |
| 05/24/2007 | WO2004034973A3 Method of treating snoring and other obstructive breathing disorders |
| 05/24/2007 | WO2003084471A3 Compositions selective for adenosine diphosphate and methods of using same |
| 05/24/2007 | US20070118108 Systems and methods for treating hemorrhoids |
| 05/24/2007 | US20070117832 Novel compound, corresponding compositons, preparation and/or treatment methods |
| 05/24/2007 | US20070117799 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 05/24/2007 | US20070117757 Polypeptide copolymer for use in treatment of multiple sclerosis; glatiramer acetate; copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons; chromatographic separation; cleaving by acid hydrolysis or enzymetic hydrolysis; isolation by dialysis or ultrafiltration, |
| 05/24/2007 | US20070116768 Sustained release preparations composed of biocompatible complex microparticles |
| 05/24/2007 | DE60119515T2 Probiotica für verwendung als haustierfutter Probiotics for use as petfood |
| 05/23/2007 | EP1787980A2 Crystalline and pure modafinil, and process of preparing the same |
| 05/23/2007 | EP1787639A2 Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 05/23/2007 | EP1786457A1 Use of il-6 in vascular complications |
| 05/23/2007 | EP1480679B1 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative |
| 05/23/2007 | CN1968951A Novel 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydroisoindol-l-one/5,6-dihydro-furo[2,3-c]pyrrol-4one derivatives ligands for alpha 7 nicotinic acetylcholine receptor |
| 05/23/2007 | CN1968685A Screening for synergistic compounds |
| 05/22/2007 | US7220761 Compounds and methods for controlling fungi, bacteria and insects |
| 05/22/2007 | US7220738 Rifamycin analogs and uses thereof |
| 05/22/2007 | US7220401 To deliver a radionuclide to a blood clot, to obtain an ultrasound image of a blood clot, for diagnosis, therapy |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/22/2007 | CA2237983C Non-invasive localization of a light-emitting conjugate in a mammal |
| 05/18/2007 | WO2006025057A8 Use of il-6 in vascular complications |
| 05/18/2007 | WO2005016241A3 Synthetic chemokine receptor ligands and methods of use thereof |
| 05/18/2007 | WO2004103275A3 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 05/18/2007 | CA2669475A1 Tissue carbohydrate compositions and analysis thereof |
| 05/17/2007 | US20070112318 Ocular drug delivery device |
| 05/17/2007 | US20070112071 Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
| 05/17/2007 | US20070111982 Calcitonin Gene-Related Peptide, CGRP; treatment of migraine and cluster headache; 2,5-dioxo-3',4'-dihydro-spiro(imidazolidine-4,2'(1'H)-naphthalene)-6'-carboxamides |
| 05/17/2007 | US20070111266 Antibodies to murine zcytor17 ligand |
| 05/17/2007 | US20070110804 Drug polymer complexes |
| 05/17/2007 | US20070110750 Monoclonal antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 05/17/2007 | US20070110718 System for treating and preventing breast cancer |
| 05/17/2007 | US20070110716 Relationship of a specific metabolite to insulin resistance |
| 05/17/2007 | US20070110706 Treatment of hyperphosphatemia using crosslinked small molecule amine polymers |
| 05/17/2007 | US20070110684 oral dental formulation capable of boosting immune response to gum diseases or tooth decay |
| 05/16/2007 | EP1785416A2 9, 10-alpha, alpha-OH-Taxane Analogs and methods for production thereof |
| 05/16/2007 | EP1784176A1 Composition comprising lactic acid and lactoferrin |
| 05/16/2007 | EP1448800A4 Digital assay |
| 05/16/2007 | CN1965024A Gelled starch compositions and methods of making gelled starch compositions |
| 05/16/2007 | CN1964960A Recovery of phytonutrients from oils |
| 05/16/2007 | CN1964721A A medical solution, a method for producing said medical solution and use thereof |
| 05/16/2007 | CN1964714A Combination methods of treating cancer |
| 05/16/2007 | CN1964695A Topical l-carnitine compositions |
| 05/16/2007 | CN1964630A Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 05/16/2007 | CN1961880A Cancer treatment. |
| 05/16/2007 | CN1315862C Methods and compositions for treating flaviviruses and pestiviruses |
| 05/16/2007 | CN1315809C Quinoline derivatives and their use as 5-HT6 ligands |
| 05/15/2007 | US7217833 May be used to prepare novel aerosol formulations, and can be advantageous in terms of improving the stability of the aerosol formulation, reducing drug deposition, increasing shelf life |
| 05/15/2007 | US7217794 peptidomimetics and non-peptides that inhibit the activity of Factor XIa; purified human Factor XI protein mutants |
| 05/15/2007 | US7217779 prepared by reacting one or more alkylphenol-formaldehyde resin alkoxylates or one or more polyalkylene glycols with one or more phosphorous compounds selected from phosphorous oxychloride, phosphorous pentoxide and phosphoric acid |
| 05/15/2007 | US7217738 β2-adrenergic receptor agonists |
| 05/15/2007 | US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses |
| 05/15/2007 | US7217709 Tetracyclic benzamide derivatives and methods of use thereof |
| 05/15/2007 | US7217704 LPA receptor agonists and antagonists and methods of use |
| 05/15/2007 | US7217420 Protective formulation that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes; formulation comprises a protective amount of live MG strain K5054 or derivatives |
| 05/15/2007 | US7217412 IL-17C related mammalian cytokine polypeptides |
| 05/15/2007 | CA2366829C Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 05/15/2007 | CA2325739C Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator |
| 05/10/2007 | WO2005037221A3 Cystatin c as an antagonist of tgf-b and methods related thereto |
| 05/10/2007 | WO2004110337A3 Cell permeable conjugates of peptides for inhibition of protein kinases |